Article
Discovery and Validation of COL11A1 as a Therapeutic Target for Sorafenib Resistance in Lung Adenocarcinoma
2026-02-06
Abstract excerpt
<title>Abstract</title> <p>Objective To investigate the expression characteristics, prognostic value, and role of COL11A1 in Sorafenib resistance in lung adenocarcinoma (LUAD). Methods The expression differences of COL11A1 in LUAD were analyzed based on The Cancer Genome Atlas (TCGA) database. Kaplan-Meier survival analysis was performed to evaluate prognostic value, and drug sensitivity analysis was conducted...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 39ffadee-2dd6-5f2d-a2da-55463313864e
- DOI
- 10.21203/rs.3.rs-8546693/v1
